2020
DOI: 10.1016/j.ejogrb.2020.03.052
|View full text |Cite
|
Sign up to set email alerts
|

Preeclampsia and low sodium (PALS): A case and systematic review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
3
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 14 publications
1
3
0
Order By: Relevance
“…Hsu et al [ 64 ] showed that hyponatremia in pre-eclampsia can lead to maternal respiratory and circulatory arrest. This is also confirmed by Powel et al [ 65 ], based on a case report of a twin pregnancy and data from the literature showing that pregnant women should be screened for water–electrolyte balance as part of a risk assessment for pre-eclampsia, as elevated Na levels can also be a risk factor for this condition [ 66 ].…”
Section: Discussionsupporting
confidence: 59%
“…Hsu et al [ 64 ] showed that hyponatremia in pre-eclampsia can lead to maternal respiratory and circulatory arrest. This is also confirmed by Powel et al [ 65 ], based on a case report of a twin pregnancy and data from the literature showing that pregnant women should be screened for water–electrolyte balance as part of a risk assessment for pre-eclampsia, as elevated Na levels can also be a risk factor for this condition [ 66 ].…”
Section: Discussionsupporting
confidence: 59%
“…Seizures can occur at sodium levels <125 mmol/L. 1 During normal pregnancy there is physiological hyponatraemia 3 that can be worsened by pre-eclampsia, 4 oxytocin administered in glucose solutions 5 and hypotonic fluid overdose. 6 Furthermore, excessive oral fluid intake can exacerbate hyponatraemia.…”
Section: Discussionmentioning
confidence: 99%
“…11 In some cases, the underlying pathology is thought to be mediated by syndrome of inappropriate ADH secretion (SIADH) and hypervolaemia. 12 Careful fluid assessment and fluid restriction in this situation is the mainstay of treatment. There is no safety data for the use of vasopressin antagonists (tolvaptan) in pregnancy.…”
Section: Peripartum Hyponatraemiamentioning
confidence: 99%